Pulmonary Function Test Study - Automated Interpretation
NCT ID: NCT03264417
Last Updated: 2018-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2017-08-01
2018-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contribution of Four Pulmonary Function Tests to Diagnosis in the Primary Care.
NCT03424083
Open, Prospective Pilot Study to Obtain Aerosol Distribution in Asthmatic Patients Using Single Photon Emission Computed Tomography (SPECT) for Comparison With Functional Imaging Using Computer Methods
NCT00966758
CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight
NCT02611947
Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease
NCT03157817
Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease
NCT02826265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A random sample of 50 lung function printouts of subjects followed at the Leuven pulmonary service with a final diagnosis of a respiratory disease have been randomised. These anonymized printouts will be given to different pulmonologists for examination in 18 different centers and compared with the interpretation of in-house developed software.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Completed one or more pulmonary function tests
Exclusion Criteria
2. Lung transplantation, lung cancer.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
AZ Sint-Jan AV
OTHER
Ziekenhuis Oost-Limburg
OTHER
Jessa Hospital
OTHER
Onze Lieve Vrouwziekenhuis Aalst
OTHER
Centre Hospitalier Universitaire de Charleroi
OTHER
University Hospital St Luc, Brussels
OTHER
Centre Hospitalier Universitaire Saint Pierre
OTHER
University of Liege
OTHER
Centre Hospitalier du Luxembourg
OTHER
Maastricht University Medical Center
OTHER
University Medical Center Nijmegen
OTHER
University Medical Center Groningen
OTHER
University Hospital, Paris
OTHER
University Hospital, Grenoble
OTHER
Philipps University Marburg
OTHER
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wim Janssens
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wim Janssens, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
UZ Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S60619
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.